NeuroWave
NeuroWave Systems Inc. is a privately held Ohio-based medical device company that sells the NeuroSENSE Monitor, a bilateral EEG brain function monitor used by hospitals and anesthesiologists to guide patient-customized anesthesia and sedation delivery.
- Company typePrivate
- Founded2003
- HeadquartersCleveland, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What NeuroWave does
NeuroWave Systems Inc. is a privately held medical device company headquartered in Beachwood, Ohio, that develops brain monitoring and drug delivery devices powered by proprietary signal processing and control engineering technologies. Its sole commercial product, the NeuroSENSE Monitor, is a bilateral brain function monitor that produces simultaneous independent indices of anesthetic effect for each cerebral hemisphere and is intended to help clinicians detect brain function asymmetry and optimize dosing during anesthesia and sedation procedures. The company targets hospitals, operating rooms, and critical care environments where anesthesia and sedation are administered, selling hardware through direct enterprise field sales supported by demonstrations at major medical conferences and clinician education programs.
The business is run as a focused single-product operation with 11-50 employees, an enterprise GTM motion centered on anesthesia specialty events (Society for Technology in Anesthesia, ASA ANESTHESIOLOGY, ESAIC, EuroSIVA, IARS, MHSRS), and no disclosed external funding, partnerships, or named customer accounts. There are no disclosed AI/ML capabilities, no FDA or CE certification filings in the source data, and no senior leadership beyond Chairman and CEO Robert Schmidt. Revenue is generated through hardware sales of the NeuroSENSE device; pricing is not publicly disclosed, and financial scale is not reported.
NeuroWave firmographics
Firmographics- Name
- NeuroWave
- Legal name
- NeuroWave Systems Inc.
- Website
- https://NeuroWaveSystems.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NeuroWave Systems Inc. is a privately held Ohio-based medical device company that sells the NeuroSENSE Monitor, a bilateral EEG brain function monitor used by hospitals and anesthesiologists to guide patient-customized anesthesia and sedation delivery.
- Ownership category
- akta.pro rank
NeuroWave industry classification
Industry- Product category
- Brain Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
Keywords
Where NeuroWave is headquartered
LocationHeadquarters
- HQ city
- Cleveland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NeuroWave business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: NeuroWave generates revenue through the sale of medical monitoring devices, specifically the NeuroSENSE Monitor system, which is a brain monitoring medical device for anesthesia and sedation delivery.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
NeuroWave product offering
Product offeringCore offering
NeuroWave develops and sells the NeuroSENSE Monitor, a bilateral brain function monitor that provides simultaneous independent indices of anesthetic effect for each side of the brain. The device is intended to help anesthesiologists and critical care clinicians detect brain function asymmetry and make optimal dosing decisions during patient-customized anesthesia and sedation delivery. The company also pursues broader brain monitoring and drug delivery medical device development backed by proprietary signal processing and control engineering technology.
Product overview
NeuroWave Systems Inc. offers a single unified product portfolio centered on the NeuroSENSE Monitor, a brain monitoring medical device. The company develops innovative brain monitoring and drug delivery medical devices powered by state-of-the-art signal processing and control engineering technologies. The NeuroSENSE Monitor serves as the core offering, providing bilateral brain function monitoring for patient-customized anesthesia and sedation delivery, with the company's vision focused on pioneering automation in anesthesia for improved and safer patient care.
Differentiator
Problem solved
Functional benefit
Brands
- NeuroSENSE® Monitor: Bilateral brain function monitor for patient-customized anesthesia and sedation delivery with simultaneous independent indices of anesthetic effect for each side of the brain.
Products and services
- NeuroSENSE Monitor A bilateral brain function monitor providing simultaneous independent indices of anesthetic effect for each side of the brain, responding instantaneously to changes in patient state. It is designed for anesthesiologists, sedation providers, and critical care clinicians in hospitals and operating room settings to detect brain function asymmetry and support safer, patient-customized anesthesia and sedation delivery.
Companies that use NeuroWave
Customer profileSegments1 record
Ideal customer profiles2 records
NeuroWave technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
NeuroWave partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights3 records
NeuroWave competitors and assessment
Company assessmentEmerging players
- BrainScope: BrainScope builds EEG-based point-of-care brain-assessment devices (for concussion/trauma), representing an emerging adjacent neuro-monitoring player that addresses similar clinical pain points with handheld EEG technology.
Direct peers
- Nihon Kohden: Nihon Kohden manufactures EEG monitors and neuro-monitoring systems used in operating rooms and ICUs, making it a focused neurodiagnostic peer with comparable bilateral/EEG monitoring capabilities to NeuroSENSE.
- Compumedics: Compumedics produces EEG and sleep/neurological monitoring systems used in clinical and research settings, directly comparable to NeuroWave's EEG-based brain monitoring approach for anesthesia and sedation.
- Masimo: Masimo's SedLine brain-function monitor and rainbow SET platform directly compete with NeuroSENSE in OR and ICU anesthesia/sedation brain monitoring, serving the same anesthesiologist buyer with similar EEG-derived indices.
- Cadwell Industries: Cadwell designs and sells EEG, EMG, and intraoperative neuro-monitoring devices, overlapping with NeuroWave's neurodiagnostic technology footprint for anesthesia and critical-care customers.
Broad incumbents
- GE HealthCare: GE HealthCare's CARESCAPE patient monitoring platform integrates EEG-based brain monitoring modules for anesthesia and ICU settings, competing broadly with NeuroWave while bundling these capabilities into larger hospital capital purchases.
- Medtronic: Medtronic offers the BIS Brain Monitoring System (inherited from Covidien) for assessing anesthetic depth, directly overlapping NeuroSENSE's use case while leveraging Medtronic's broader patient-monitoring portfolio and global hospital sales network.
- Philips: Philips IntelliVue and related perioperative monitoring solutions include EEG/brain-function options for anesthesia and sedation, overlapping NeuroWave's clinical use cases while benefiting from Philips' enterprise hospital footprint.
Market position
Weaknesses4 records
Competitive moat3 records
Key risks7 records
Key highlights6 records
Customer concentration
NeuroWave financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroWave leadership team
Management profileNumber of profiles
Profiles1 record
NeuroWave funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroWave M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroWave
What does NeuroWave do?
NeuroWave develops and sells the NeuroSENSE Monitor, a bilateral brain function monitor that provides simultaneous independent indices of anesthetic effect for each side of the brain. The device is intended to help anesthesiologists and critical care clinicians detect brain function asymmetry and make optimal dosing decisions during patient-customized anesthesia and sedation delivery. The company also pursues broader brain monitoring and drug delivery medical device development backed by proprietary signal processing and control engineering technology.
Is NeuroWave a public or private company?
NeuroWave is a private company. It is classified as unknown and is currently operating.
When was NeuroWave founded?
NeuroWave was founded in 2003. It employs 11 to 50 people.
Where is NeuroWave based?
NeuroWave is headquartered in Cleveland, United States, in the North America region.
How does NeuroWave make money?
One revenue line is on record: medical Device Sales.
Who are NeuroWave's main competitors?
BrainScope is listed as an emerging player. Direct peers are Nihon Kohden, Compumedics, Masimo and Cadwell Industries. Broad incumbents are GE HealthCare, Medtronic and Philips.
Does NeuroWave have an API?
No public API is recorded for NeuroWave.
What industry is NeuroWave in?
NeuroWave's product category is Brain Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 334510 and its SIC code is 3845.